SUNPHARMA delivered a strong weekly return of 2.78%, outperforming peers DRREDDY and HINDUNILVR, but slightly underperforming DIVISLAB. The stock's volatility was relatively moderate at 14.86%, indicating a manageable risk level. With a Sharpe Ratio of 0.74, SUNPHARMA's return was decently compensated for the risk taken. Overall, the stock's performance was positive, with a maximum drawdown of -0.7% indicating a relatively stable week.

[Volatility: 14.86%]